Insider · CIK 0001339895

Dickinson Klara

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001339895

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-22	CymaBay Therapeutics, Inc.D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−21K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−200K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−100K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−138K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−328K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−66.5K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−175K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−215K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−78K sh	—	—	0
2024-01-24	CymaBay Therapeutics, Inc.A Award	Chief Regulatory Officer	AAward	+21K sh	—	—	21,000
2024-01-24	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+78K sh	—	—	78,000
2023-01-25	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+215K sh	—	—	215,000
2022-01-25	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+175K sh	—	—	175,000
2021-01-26	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+66.5K sh	—	—	66,500
2020-05-15	CymaBay Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Regulatory Officer	AAward	+328K sh	—	—	328,299
2019-01-29	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+138K sh	—	—	138,312
2018-01-24	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+100K sh	—	—	100,000
2017-06-28	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+200K sh	—	—	200,000
2017-05-20	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Regulatory Officer	AAward	+43.8K sh	—	—	43,750
2016-06-09	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Regulatory Officer	AAward	+105K sh	—	—	105,000
2016-02-12	Anthera Pharmaceuticals IncStock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+8,395 sh	—	—	8,395
2015-09-17	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Regulatory Officer	AAward	+50K sh	—	—	50,000
2015-09-17	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Chief Regulatory Officer	AAward	+30K sh	—	—	30,000
2015-06-30	Anthera Pharmaceuticals IncA Award	Chief Regulatory Officer	AAward	+12.5K sh	$1.49	+$18.6K	12,500
2014-03-11	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)A Award	SVP Reg. Affairs & Compliance	AAward	+12K sh	—	—	12,000
2014-03-11	HYPERION THERAPEUTICS INCA Award	SVP Reg. Affairs & Compliance	AAward	+2,000 sh	—	—	2,283
2013-04-15	HYPERION THERAPEUTICS INCStock Option (right to buy)A Award	SVP Reg. Affairs & Compliance	AAward	+43K sh	—	—	43,000
2012-07-31	HYPERION THERAPEUTICS INCC Conversion	SVP Reg. Affairs & Compliance	CConversion	+278 sh	—	—	283
2012-07-31	HYPERION THERAPEUTICS INCSeries C-1 Preferred StockC Conversion	SVP Reg. Affairs & Compliance	CConversion	−278 sh	—	—	0
2006-06-30	COTHERIX INCStock Option (Right to Buy)A Award	VP, Regulatory Affairs	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Mar 224
Dickinson Klara0000950170-24-035458
SEC(opens sec.gov)
Jan 264
Dickinson Klara0001062993-24-001433
SEC(opens sec.gov)
Jan 274
Dickinson Klara0001062993-23-001491
SEC(opens sec.gov)
Jan 274
Dickinson Klara0001062993-22-001701
SEC(opens sec.gov)
Jan 284
Dickinson Klara0001333277-21-000022
SEC(opens sec.gov)
May 194
Dickinson Klara0001209191-20-030585
SEC(opens sec.gov)
Jan 314
Dickinson Klara0001333277-19-000030
SEC(opens sec.gov)
Jan 264
Dickinson Klara0001333277-18-000023
SEC(opens sec.gov)
Jun 304
CymaBay Therapeutics, Inc.0001042074-17-000008
SEC(opens sec.gov)
May 224
Anthera Pharmaceuticals Inc0001214659-17-003555
SEC(opens sec.gov)
Jun 134
Anthera Pharmaceuticals Inc0001214659-16-012181
SEC(opens sec.gov)

Companies

Address

C/O HYPERION THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 200

SOUTH SAN FRANCISCO, CA, 94080